| Dr David Marc Smith, MD | |
|
2700 Nw Stewart Pkwy, Roseburg, OR 97470-1281 | |
| (541) 584-2345 | |
| (541) 584-2345 |
| Full Name | Dr David Marc Smith |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 2700 Nw Stewart Pkwy, Roseburg, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235100215 | NPI | - | NPPES |
| 059290 | Medicaid | OR | |
| 930069800 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD15989 (Oregon) | Primary |
| Entity Name | Southern Coos Health District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588684484 PECOS PAC ID: 1951219310 Enrollment ID: O20040526000542 |
News Archive
British scientists warn that well known brands of hay fever tablets, painkillers and sleeping pills pose a previously unknown threat to elderly people's health when taken together. Many are available over the counter at pharmacies as well as being prescribed by GPs, nurses and chemists they said.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.
StemCells, Inc. announced today that it has entered into an agreement to raise approximately $12.5 million in gross proceeds through the sale of approximately 10 million shares of its common stock to selected institutional investors at a price of $1.25 per share. The investors will also receive warrants to purchase approximately four million shares of common stock at an exercise price of $1.50 per share.
As we approach World AIDS Day, observed globally December 1, we are reminded that while progress has been made in expanding access to treatment and prevention and that progress has been made toward the development of new prevention tools, the world is still falling short of established targets for providing universal access to HIV and AIDS prevention, treatment and care by 2010. Nearly 5.5 million of the estimated 9.5 million people in need of antiretroviral therapy are still not receiving it.
NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS- System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication.
› Verified 5 days ago
| Entity Name | Cep America Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780647719 PECOS PAC ID: 6608056171 Enrollment ID: O20130123000079 |
News Archive
British scientists warn that well known brands of hay fever tablets, painkillers and sleeping pills pose a previously unknown threat to elderly people's health when taken together. Many are available over the counter at pharmacies as well as being prescribed by GPs, nurses and chemists they said.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.
StemCells, Inc. announced today that it has entered into an agreement to raise approximately $12.5 million in gross proceeds through the sale of approximately 10 million shares of its common stock to selected institutional investors at a price of $1.25 per share. The investors will also receive warrants to purchase approximately four million shares of common stock at an exercise price of $1.50 per share.
As we approach World AIDS Day, observed globally December 1, we are reminded that while progress has been made in expanding access to treatment and prevention and that progress has been made toward the development of new prevention tools, the world is still falling short of established targets for providing universal access to HIV and AIDS prevention, treatment and care by 2010. Nearly 5.5 million of the estimated 9.5 million people in need of antiretroviral therapy are still not receiving it.
NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS- System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Marc Smith, MD 2700 Nw Stewart Pkwy, Roseburg, OR 97470-1281 Ph: (541) 584-2345 | Dr David Marc Smith, MD 2700 Nw Stewart Pkwy, Roseburg, OR 97470-1281 Ph: (541) 584-2345 |
News Archive
British scientists warn that well known brands of hay fever tablets, painkillers and sleeping pills pose a previously unknown threat to elderly people's health when taken together. Many are available over the counter at pharmacies as well as being prescribed by GPs, nurses and chemists they said.
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new approach to alter the function of RNA in living cells by designing molecules that recognize and disable RNA targets. As a proof of principle, in the new study the team designed a molecule that disabled the RNA causing myotonic dystrophy.
StemCells, Inc. announced today that it has entered into an agreement to raise approximately $12.5 million in gross proceeds through the sale of approximately 10 million shares of its common stock to selected institutional investors at a price of $1.25 per share. The investors will also receive warrants to purchase approximately four million shares of common stock at an exercise price of $1.50 per share.
As we approach World AIDS Day, observed globally December 1, we are reminded that while progress has been made in expanding access to treatment and prevention and that progress has been made toward the development of new prevention tools, the world is still falling short of established targets for providing universal access to HIV and AIDS prevention, treatment and care by 2010. Nearly 5.5 million of the estimated 9.5 million people in need of antiretroviral therapy are still not receiving it.
NeuroPace, Inc. today announced that results from its pivotal trial demonstrated the RNS- System, a novel investigational device that utilizes responsive brain neurostimulation, significantly reduced the frequency of seizures among people who have a common form of epilepsy that is difficult to treat with medication.
› Verified 5 days ago
Tami Sue Marriott, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2700 Nw Stewart Pkwy, Roseburg, OR 97471 Phone: 541-677-4333 | |
William S Treloar, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2700 Nw Stewart Pkwy, Roseburg, OR 97470 Phone: 541-677-4313 Fax: 541-677-4533 | |
Dr. Scott Christian Smith, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Nw Stewart Pkwy, Roseburg, OR 97471 Phone: 541-673-0611 | |
Dr. Daniel Joseph Hull, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Nw Stewart Pkwy, Roseburg, OR 97471 Phone: 541-677-2185 Fax: 541-677-2291 | |
Tierney Elizabeth Flodine, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2570 Nw Edenbower Blvd Ste 100, Roseburg, OR 97471 Phone: 541-677-7200 Fax: 541-229-3309 | |
Dr. Ryan Jon Petersen, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Nw Stewart Pkwy, Roseburg Or 97471, Roseburg, OR 97471 Phone: 314-750-3965 |